Deep gray matter and fatigue in MS: A T1 relaxation time study

Journal of Neurology

Volumn 253, Issue 7, 2006, Pages 896-902

  Niepel, G ^a   Tench, Ch R ^a   Morgan, P S ^a   Evangelou, N ^a   Auer, D P ^a   Constantinescu, C S ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Fatigue; Gray matter; MRI; Multiple sclerosis; T1 relaxation time

Indexed keywords

ADULT; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FATIGUE; FEMALE; GRAY MATTER; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; PUTAMEN; RATING SCALE; THALAMUS;

ADULT; BRAIN; CAUDATE NUCLEUS; DISEASE PROGRESSION; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS; NEURAL PATHWAYS; NEURONS; PREDICTIVE VALUE OF TESTS; PUTAMEN; THALAMUS; TIME FACTORS;

EID: 33746218470     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-006-0128-9     Document Type: Article

References (44)

1. MSCfCP Guidelines (1998) Fatigue and multiple sclerosis: evidence-based management strategies for fatigue in multiple sclerosis In: Multiple Sclerosis Council for Clinical Practice Guidelines, Washington, DC
2. Janardhan V, Bakshi R (2002) Quality of life in patients with multiple sclerosis: the impact of fatigue and depression. J Neurol Sci 205:51-58
3. Freal JE, Kraft GH, Coryell JK (1984) Symptomatic fatigue in multiple sclerosis. Arch Phys Med Rehabil 65: 135-138
4. Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC (1988) Fatigue in multiple sclerosis. Arch Neurol 45:435-437
5. Miller RG, Green AT, Moussavi RS, Carson PJ, Weiner MW (1990) Excessive muscular fatigue in patients with spastic paraparesis. Neurology 40: 1271-1274
6. Sheean GL, Murray NM, Rothwell JC, Miller DH, Thompson AJ (1997) An electrophysiological study of the mechanism of fatigue in multiple sclerosis. Brain 120(Pt 2):299-315
7. Tartaglia MC, Narayanan S, Francis SJ, Santos AC, De Stefano N, Lapierre Y, Arnold DL (2004) The relationship between diffuse axonal damage and fatigue in multiple sclerosis. Arch Neurol 61:201-207
8. Roelcke U, Kappos L, Lechner-Scott J, Brunnschweiler H, Huber S, Ammann W, Plohmann A, Dellas S, Maguire RP, Missimer J, Radu EW, Steck A, Leenders KL (1997) Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study. Neurology 48: 1566-1571
9. Filippi M, Rocca MA, Colombo B, Falini A, Codella M, Scotti G, Comi G (2002) Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis. Neuroimage 15:559-567
10. Codella M, Rocca MA, Colombo B, Martinelli-Boneschi F, Comi G, Filippi M (2002) Cerebral grey matter pathology and fatigue in patients with multiple sclerosis: a preliminary study. J Neurol Sci 194:71-74
11. Colombo B, Martinelli Boneschi F, Rossi P, Rovaris M, Maderna L, Filippi M, Comi G (2000) MRI and motor evoked potential findings in nondisabled multiple sclerosis patients with and without symptoms of fatigue. J Neurol 247:506-509
12. Bakshi R, Miletich RS, Henschel K, Shaikh ZA, Janardhan V, Wasay M, Stengel LM, Ekes R, Kinkel PR (1999) Fatigue in multiple sclerosis: cross-sectional correlation with brain MRI findings in 71 patients. Neurology 53:1151-1153
13. Truyen L, van Waesberghe JH, van Walderveen MA, van Oosten BW, Polman CH, Hommes OR, Ader HJ, Barkhof F (1996) Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology 47:1469-1476
14. van Walderveen MA, Barkhof F, Pouwels PJ, van Schijndel RA, Polman CH, Castelijns JA (1999) Neuronal damage in T1-hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy. Ann Neurol 46:79-87
15. Parry A, Clare S, Jenkinson M, Smith S, Palace J, Matthews PM (2002) White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis. J Neurol 249:1279-1286
16. Griffin CM, Chard DT, Parker GJ, Barker GJ, Thompson AJ, Miller DH (2002) The relationship between lesion and normal appearing brain tissue abnormalities in early relapsing remitting multiple sclerosis. J Neurol 249: 193-199
17. van Walderveen MA, van Schijndel RA, Pouwels PJ, Polman CH, Barkhof F (2003) Multislice T1 relaxation time measurements in the brain using IR-EPI: reproducibility, normal values, and histogram analysis in patients with multiple sclerosis. J Magn Reson Imaging 18:656-664
18. van Waesberghe JH, Castelijns JA, Scheltens P, Truyen L, Lycklana ANGJ, Hoogenraad FG, Polman CH, Valk J, Barkhof F (1997) Comparison of four potential MR parameters for severe tissue destruction in multiple sclerosis lesions. Magn Reson Imaging 15: 155-162
19. Vaithianathar L, Tench CR, Morgan PS, Constantinescu CS (2003) Magnetic resonance imaging of the cervical spinal cord in multiple sclerosis - a quantitative T1 relaxation time mapping approach. J Neurol 250:307-315
20. Vaithianathar L, Tench CR, Morgan PS, Wilson M, Blumhardt LD (2002) T1 relaxation time mapping of white matter tracts in multiple sclerosis defined by diffusion tensor imaging. J Neurol 249: 1272-1278
21. Morgan PS, Moody AR, Tench CR, Vaithianathar L (2001) Rapid 3D T1 mapping ISMRM, Glasgow, UK 898
22. Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46:907-911
23. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50: 121-127
24. Kurtzke J (1984) Disability rating scales in multiple sclerosis. Ann NY Acad Sci 436:347-360
25. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989) The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46: 1121-1123
26. Sonka M, Hlavac V, Boyle R (1998) Image Processing, Analysis and Machine Vision. Brooks and Cole Publishing, California
27. Cifelli A, Arridge M, Jezzard P, Esiri MM, Palace J, Matthews PM (2002) Thalamic neurodegeneration in multiple sclerosis. Ann Neurol 52:650-653
28. Wylezinska M, Cifelli A, Jezzard P, Palace J, Alecci M, Matthews PM (2003) Thalamic neurodegeneration in relapsing-remitting multiple sclerosis. Neurology 60:1949-1954
29. Davies GR, Altmann DR, Rashid W, Chard DT, Griffin CM, Barker GJ, Kapoor R, Thompson AJ, Miller DH (2005) Emergence of thalamic magnetization transfer ratio abnormality in early relapsing-remitting multiple sclerosis. Mult Scler 11:276-281
30. Carone DA, Benedict RH, Dwyer MG, Cookfair DL, Srinivasaraghavan B, Tjoa CW, Zivadinov R (2006) Semi-automatic brain region extraction (SABRE) reveals superior cortical and deep gray matter atrophy in MS. Neuroimage 29:505-514
31. Barnes D, McDonald WI, Landon DN, Johnson G (1988) The characterization of experimental gliosis by quantitative nuclear magnetic resonance imaging. Brain 111(Pt 1):83-94
32. Barnes D, McDonald WI, Johnson G, Tofts PS, Landon DN (1987) Quantitative nuclear magnetic resonance imaging: characterisation of experimental cerebral oedema. J Neurol Neurosurg Psychiatry 50:125-133
33. van Waesberghe JH, Kamphorst W, De Groot CJ, van Walderveen MA, Castelijns JA, Ravid R, Lycklama a Nijeholt GJ, van der Valk P, Polman CH, Thompson AJ, Barkhof F (1999) Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 46:747-754
34. Brownell B, Hughes JT (1962) The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatry 25:315-320
35. Huitinga I, De Groot CJ, Van der Valk P, Kamphorst W, Tilders FJ, Swaab DF (2001) Hypothalamic lesions in multiple sclerosis. J Neuropathol Exp Neurol 60:1208-1218
36. Peterson JW, Bo L, Mork S, Chang A, Trapp BD (2001) Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 50:389-400
37. Sawlani V, Gupta RK, Singh MK, Kohli A (1997) MRI demonstration of Wallerian degeneration in various intracranial lesions and its clinical implications. J Neurol Sci 146:103-108
38. Simon JH, Kinkel RP, Jacobs L, Bub L, Simonian N (2000) A Wallerian degeneration pattern in patients at risk for MS. Neurology 54:1155-1160
39. Cookfair DL, Fischer J, Rudick R, Jacobs L, Herndon R, Richert J, Granger C, Simon J, Goodkin D (1997) Fatigue severity in low disability MS patients participating in a phase III trial of Avonex (IFNb-1a) for relapsing multiple sclerosis. Neurology 48(Suppl 2):A173 (Abstract)
40. Mainero C, Faroni J, Gasperini C, Filippi M, Giugni E, Ciccarelli O, Rovaris M, Bastianello S, Comi G, Pozzilli C (1999) Fatigue and magnetic resonance imaging activity in multiple sclerosis. J Neurol 246:454-458
41. Bruno RL, Creange SJ, Frick NM (1998) Parallels between post-polio fatigue and chronic fatigue syndrome: a common pathophysiology? Am J Med 105: 66S-73S
42. Schuurman PR, Bosch DA, Bossuyt PM, Bonsel GJ, van Someren EJ, de Bie RM, Merkus MP, Speelman JD (2000) A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med 342:461-468
43. Hua Z, Guodong G, Qinchuan L, Yaqun Z, Qinfen W, Xuelian W (2003) Analysis of complications of radiofrequency pallidotomy. Neurosurgery 52:89-101
44. Bhatia KP, Marsden CD (1994) The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain 117(Pt 4):859-876